xCures launches xACCESS - A new module in their AI-assisted clinical platform

Al's Comment:

 Through a collaboration with Cancer Commons and xCures, the Musella Foundation is proud to offer our patients free access to this system. View the press release and watch the video to see how the program works.  This module is what powers our "A Patient-Centric Platform Trial for Precision Oncology"  NCT03793088. 

 

This program will evaluate you and help find the best treatment options for your specific case. We then try to help you get access to them if needed. Then we follow up to see what treatments you do and the outcome so we learn from every patient.  To get started, go to Virtualtrials.org and click on FIND TREATMENTS then on FULL SERVICE.

 

The Musella Foundation is focused on Brain Tumors, but Cancer Commons  also handles these tumor types: Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer, Melanoma, Non Small Cell Lung Cancer, Thyroid Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Esophageal Cancer, Cholangiocarcinoma, Ovarian Cancer, and Hepatocellular Carcinoma. It also handles any type of cancer that has one of these specific mutations: MAPK, KRAS, BRAF, NRAS, HRAS, MEK and ERK. For details go to Cancer Commons.Org

 

Disclaimer: Al Musella owns stock in xCures.

 


Posted on: 11/17/2020 [Click the link below for full article]

xCures launches xACCESS - A new module in their AI-assisted clinical platform

 


Click HERE to return to brain tumor news headlines.